Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis C virus in childhood and pregnancy.

Infectious diseases & immunity·2026
Same author

HVEM-LIGHT signaling promotes antibody-dependent neutrophil FcγR-mediated trogocytosis against herpes simplex virus infection.

The Journal of clinical investigation·2026
Same author

A cell-impermeable kinase inhibitor uncovers outside-in signaling pathways that promote HIV-1 infection.

Journal of virology·2026
Same author

Targeting epithelial stress and inflammation through p53: therapeutic implications for pulmonary fibrosis.

American journal of respiratory and critical care medicine·2026
Same author

Distinct prokaryotic gut microbiome and proviral-immune axes of pathophysiology in Sickle Cell Disease.

bioRxiv : the preprint server for biology·2026
Same author

A drug-microbiome-drug interaction impacts co-prescribed medications for Parkinson's disease.

Nature microbiology·2026

Related Experiment Video

Updated: Feb 19, 2026

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System
07:32

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System

Published on: August 30, 2019

9.3K

Microbiota control immune regulation in humanized mice.

Elke Gülden1, Nalini K Vudattu1, Songyan Deng1

  • 1Department of Immunobiology.

JCI Insight
|November 3, 2017
PubMed
Summary

Altering the gut microbiome with antibiotics impacts immune cell regulation and reduces the efficacy of immunosuppressive therapies like teplizumab in humanized mice. This highlights the microbiome's role in modulating immune responses.

More Related Videos

Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure
05:34

Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure

Published on: December 13, 2024

1.1K
Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery
05:15

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Published on: September 27, 2021

1.6K

Related Experiment Videos

Last Updated: Feb 19, 2026

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System
07:32

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System

Published on: August 30, 2019

9.3K
Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure
05:34

Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure

Published on: December 13, 2024

1.1K
Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery
05:15

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Published on: September 27, 2021

1.6K

Area of Science:

  • Immunology
  • Microbiome research
  • Pharmacology

Background:

  • The gut microbiome significantly influences immune system development and function.
  • Its role in modulating immune therapies in vivo remains incompletely understood.
  • Humanized mouse models offer a platform to study host-microbiome-immune interactions.

Purpose of the Study:

  • To investigate how microbiome alterations affect the regulation of human immune cells in vivo.
  • To determine the impact of antibiotic-induced microbiome changes on immune cell populations and cytokine profiles.
  • To assess the consequences of microbiome modulation on the efficacy of teplizumab, an anti-CD3 antibody.

Main Methods:

  • Humanized mice were treated with a four-antibiotic cocktail to deplete the microbiome.
  • Flow cytometry and cytokine analysis (IFN-γ, IL-10, IL-27) were used to assess immune cell populations and inflammatory markers.
  • Xenograft rejection models were employed to evaluate the therapeutic efficacy of teplizumab.
  • Co-culture experiments with dendritic cells (DCs) and T cells were performed to elucidate cellular mechanisms.

Main Results:

  • Antibiotic treatment increased effector T cells, circulating IFN-γ, and anti-nuclear antibodies.
  • Teplizumab efficacy, indicated by delayed xenograft rejection and increased CD8+ central memory cells and IL-10, was abrogated.
  • Antibiotic-treated DCs exhibited reduced IL-10 and IL-27 production and enhanced T cell activation markers.
  • Human peripheral blood mononuclear cells cultured with human stool samples showed similar alterations in IL-10 induction.

Conclusions:

  • Alterations in the gut microbiome can significantly impact immune regulatory pathways.
  • Changes induced by antibiotics may reduce the efficacy of immunosuppressive medications.
  • Targeting the microbiome could be a strategy to enhance or restore the effectiveness of immunotherapies.